Expression of bomapin, a novel human serpin, in normal/malignant hematopoiesis and in the monocytic cell lines THP-1 and AML-193

Blood

Volumn 91, Issue 4, 1998, Pages 1256-1262

  Riewald, Matthias ^b   Chuang, Trinette ^b   Neubauer, Andreas ^b   Riess, Hanno ^b   Schleef, Raymond R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOMAPIN; SERINE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HEMATOPOIESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032519783     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.4.1256     Document Type: Article

References (28)

1. Huber R, Carrell RW: Implications of the three-dimensional structure of al-antitrypsin for structure and function of serpins. Biochemistry 28:8951, 1989
2. Potempa J, Korzus E, Travis J: The serpin superfamily of protease inhibitors: Structure, function and regulation. J Biol Chem 269:15957. 1994
3. Remold-O'Donnell E: The ovalbumin family of serpin proteins. FEBS Lett 315:105, 1993
4. Ye RD, Wun T, Sadler JE: cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta. J Biol Chem 262:3718, 1987
5. Remold-O'Donnell E, Chin J, Alberts M: Sequence and molecular characterization of human monocyte/neutrophil elastase inhibitor. Proc Natl Acad Sci USA 89:5635, 1992
6. Suminami Y, Kishi F, Sekiguchi K, Kato H: Squamous cell carcinoma antgen is a new member of the serine protease inhibitors. Biochem Biophys Res Commun 181:51, 1991
7. Morgenstern KA, Sprecher C, Holth L, Foster D, Grant FJ, Ching A, Kisiel W: Complementary DNA cloning and kinetic characterization of a novel intracellular serine proteinase inhibitor: Mechanism of action with trypsin and factor Xa as model proteinases. Biochemistry 33:3432, 1994
8. Coughlin P, Sun J, Cerruti L, Salem HH, Bird P: Cloning and molecular characterization of a human intracellular serine proteinase inhibitor. Proc Natl Acad Sci USA 90:9417, 1993
9. Zou Z, Anisowicz A, Hendrix MJC, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263:526, 1994
10. Sprecher CA, Morgenstern KA, Mathewes S, Dahlen JR, Schrader SK, Foster DC, Kisiel W: Molecular cloning, expression, and partial characterization of two novel members of the ovalbumin family of serine proteinase inhibitors. J Biol Chem 270:29854, 1995
11. Sun J, Bird Ch, Sutton V, McDonald L, Coughlin PB, De Jong TA, Trapani JA, Bird PI: A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J Biol Chem 271:27802, 1996
12. Riewald M, Schleef RR: Molecular cloning of bomapin (protease inhibitor 10), a novel human serpin that is expressed specifically in the bone marrow. J Biol Chem 270:26754, 1995
13. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C: Proposals for the classification of chronic (mature) B and T lymphoid leukemias. J Clin Pathol 42:567, 1989
14. Lang IM, Moser KM, Schleef RR: Expression of Kunitz protease inhibitor-containing forms of amyloid β-protein precursor within vascular thrombi. Circulation 94:2728, 1996
15. Ponte P, Ng J, Engel P, Gunning P, Kedes L: Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 12:1687, 1984
16. Tso JY, Sun X, Kao T, Reece KS, Wu R: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs; genomic complexity and molecular evaluation of the gene. Nucleic Acids Res 13:2485, 1985
17. Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA Jr, Loskutoff DJ: Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 263:5797, 1988
18. Estelles A, Gilabert J, Keeton M, Eguchi Y, Aznar J, Espana F, Loskutoff DJ, Schleef RR: Altered expression of plasminogen activator inhibitor type 1 (PAI-1) and type 2 (PAI-2) in placentas from pregnant women with preeclampsia (PE) and/or intrauterine fetal growth retardation (IUGR). Fibrinolysis 6:124, 1993
19. Riewald M, Schleef RR: Human cytoplasmic antiproteinase neutralizes rapidly and efficiently chymotrypsin and trypsin-like proteases utilizing distinct reactive site residues. J Biol Chem 271:14526, 1996
20. Lang IM, Chuang TL, Barbas III CF, Schleef RR: Purification of storage granule protein-23 A novel protein identified by phage display technology and interaction with type-1 plasminogen activator inhibitor. J Biol Chem 271:30126, 1996
21. Schleef RR, Higgins DL, Pillemer E, Levitt JJ: Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor. J Clin Invest 83:1747, 1989
22. Riewald M, Morgenstern KA, Schleef RR: Identification and characterization of the cytoplasmic antiproteinase (CAP) in human platelets. Evidence for the interaction of CAP with endogenous platelet proteins. J Biol Chem 271:7160, 1996
23. Wohlwend A, Belin D, Vassalli J: Plasminogen activator-specific inhibitors produced by human monocytes/macrophages. J Exp Med 165:320, 1987
24. Schleuning WD, Medcalf RL, Hession C, Rothenbuhler R, Shaw A, Kruithof EKO: Plasminogen activator inhibitor 2: Regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells. Mol Cell Biol 7:4564, 1987
25. Genton C, Kruithof EKO, Schleuning WD: Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells. J Cell Biol 104:705, 1987
26. Remold-O'Donnell E: A fast-acting elastase inhibitor in human monocytes. J Exp Med 162:2142, 1985
27. Scott FL, Coughlin PB, Bird C, Cerruti L, Hayman JA, Bird P: Proteinase inhibitor 6 cannot be secreted, which suggests it is a new type of cellular serpin. J Biol Chem 271:1605, 1996
28. Jensen PH, Jensen TG, Laug WE, Hager H, Gliemann J, Pepinsky B: The exon 3 encoded sequence of the intracellular serine proteinase inhibitor plasminogen activator inhibitor 2 is a protein binding domain. J Biol Chem 271:26892, 1996